Finance

Lists
600267:SHA
Zhejiang Hisun Pharmaceutical Co., Ltd.
CNÂ¥12.95
+1.81%
(+0.23) 1D
Oct 30, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600267...
Open
CNÂ¥12.64
High
CNÂ¥13.43
Low
CNÂ¥12.34
Mkt. cap
15.28B
Avg. vol.
32.96M
Volume
41.97M
Dividend
1.62%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jun 16, 2026
P/E ratio
12.28
52-wk high
CNÂ¥15.00
52-wk low
CNÂ¥9.35
EPS
CNÂ¥1.05
Shares outstanding
965.53M
No. of employees
9K
Open
CNÂ¥12.64
High
CNÂ¥13.43
Low
CNÂ¥12.34
Mkt. cap
15.28B
Avg. vol.
32.96M
Volume
41.97M
Dividend
1.62%
Quarterly dividend
CNÂ¥0.05
Ex-dividend date
Jun 16, 2026
P/E ratio
12.28
52-wk high
CNÂ¥15.00
52-wk low
CNÂ¥9.35
EPS
CNÂ¥1.05
Shares outstanding
965.53M
No. of employees
9K
News stories
From web sources and news partners
About Zhejiang Hisun Pharmaceutical Co., Ltd.
CEO-
Employees8.75K
Founded1956
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.63B
2.39B
2.09B
2.05B
Cost of goods sold
1.58B
1.17B
873.36M
664.13M
Cost of revenue
1.58B
1.17B
873.36M
664.13M
Research and development expenses
106.39M
134.44M
133.58M
134.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
723.79M
706.45M
704.72M
611.69M
Operating expense
897.41M
845.10M
888.74M
719.68M
Total operating expenses
2.48B
2.02B
1.76B
1.38B
Operating income
149.99M
370.87M
322.92M
661.48M
Other non operating income
21.53M
-3.69M
2.98M
-71.83M
EBT including unusual items
195.64M
482.46M
341.12M
575.00M
EBT excluding unusual items
149.16M
529.80M
308.48M
644.47M
Income tax expense
116.21M
123.91M
57.95M
61.65M
Effective tax rate
59.40%
25.68%
16.99%
10.72%
Other operating expenses
61.27M
12.09M
27.00M
-11.02M
Net income
79.78M
355.69M
280.78M
509.22M
Net profit margin
3.04%
14.88%
13.47%
24.90%
Earnings per share
-
-
-
-
Interest and investment income
3.79M
179.34M
2.40M
46.96M
Interest expense
-21.61M
-16.72M
-11.96M
-
Net interest expenses
-17.82M
162.62M
-9.56M
46.96M
Depreciation and amortization charges
-
-
-
-
EBITDA
388.47M
609.35M
551.54M
899.96M
Gain or loss from assets sale
-5.23M
-
-849.83K
849.83K
Upcoming events
AI content may include mistakes. Learn more
Google apps